Kensana Health Acquires ABcann Medicinals Napanee Facility From MediPharm Labs for $5.5M

MediPharm Labs Corp. Acquires VIVO Cannabis Inc.

April 1, 2023

Pharmaceuticals

Effective April 1, 2023, MediPharm Labs Corp. completed an all-equity arrangement to acquire all outstanding shares of VIVO Cannabis Inc., making VIVO a wholly-owned subsidiary. Under the arrangement, former VIVO shareholders received 0.2910 MediPharm common shares per VIVO share and MediPharm issued approximately 107,930,964 shares as consideration; VIVO shares are expected to be delisted from the Toronto Stock Exchange.

Hempsana Holdings Ltd. Completes Acquisition of Hempsana Inc.

July 12, 2021

Pharmaceuticals

Hempsana Holdings Ltd. (formerly Stralak Resource Inc.) completed a previously announced three‑cornered amalgamation to acquire Hempsana Inc., making Hempsana a wholly‑owned subsidiary. The combined company will focus on manufacturing cannabis derivatives and extracts (including vapeables, topicals and infused consumables) from Hempsana's Health Canada standard processing licensed and EU‑GMP‑compliant facility; HHL's shares are expected to trade on the Canadian Securities Exchange under the ticker HMPS.

PharmaForceIQ Acquires Aktana

January 9, 2026

Cloud & SaaS

PharmaForceIQ has acquired Aktana in an asset acquisition to integrate Aktana's AI-driven field Next-Best-Action platform into PharmaForceIQ's digital orchestration offering. The deal is intended to create an end-to-end 'optichannel-in-a-box' commercial engagement solution for life sciences, deepen PharmaForceIQ's U.S. footprint and expand reach across LATAM, APAC and EMEA; Canaccord Genuity acted as sole financial advisor.

Isracann Biosciences to Acquire Praesidio Health

February 23, 2022

Biotechnology

Isracann Biosciences Inc. entered into a binding letter of intent to acquire Canadian medical research company Praesidio Health Inc. under a stock transaction valued at approximately CAD 4.0 million. Praesidio develops and validates evidence-based natural health medicines (including formulations with cannabinoids and/or psilocybin) for conditions such as urological disorders, anxiety/stress, immune support and sleep.

MariMed Acquires Kind Therapeutics USA

April 27, 2022

Consumer Products

MariMed Inc. completed the acquisition of Kind Therapeutics U.S.A., LLC, a vertically integrated medical cannabis operator in Maryland. MariMed—an OTCQX-listed multi-state cannabis operator based in Norwood, Massachusetts—plans to expand Kind's cultivation canopy, add a GMP kitchen, and roll out new cannabis brands and products across the Maryland market.

HempFusion Acquires Apothecanna

May 17, 2021

Consumer Products

HempFusion Wellness Inc. has acquired 100% of APCNA Holdings LLC (Apothecanna) for initial consideration of US$15.0 million, with up to US$10.0 million in additional milestone payments tied to revenue targets. The deal expands HempFusion's retail distribution (adding ~1,800 stores including CVS), bolsters its e-commerce presence, and is immediately accretive based on Apothecanna's ~US$3.8–4.0 million 2020 revenue.